•
Mar 31, 2022

Seres Therapeutics Q1 2022 Earnings Report

Total Revenue
$1.49M
Previous year: $5.72M
-73.9%
EPS
-$0.61
Previous year: -$0.39
+56.4%
Gross Profit
$517K
Previous year: -$23.6M
-102.2%
Cash and Equivalents
$153M
Previous year: $66.6M
+130.1%
Free Cash Flow
-$69.4M
Previous year: -$30.8M
+125.0%
Total Assets
$320M
Previous year: $306M
+4.6%

Seres Therapeutics

Seres Therapeutics